Cited by — Preclinical characterization of EGT710, an oral non-peptidomimetic reversible covalent SARS-CoV-2 main protease inhibitor | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Preclinical characterization of EGT710, an oral non-peptidomimetic reversible covalent SARS-CoV-2 main protease inhibitor.
No admitted local citation edges point to this work yet.
